Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | FCGR1A | P12314 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2608434 | 0.84 | ALDH1A1 (0.61) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL16202075 | 0.83 | POLB (0.55) | CYP1A2CYP2C19GAAHPGDALDH1A1 | |
| SCHEMBL24185597 | 0.83 | TP53 (0.50) | MAPK1CYP1A2CYP2C19NPC1RAB9A | |
| SCHEMBL597566 | 0.83 | ALDH1A1 (0.45) | MAPK1CYP1A2CYP2C19GAAALDH1A1 | |
| SCHEMBL31067457 | 0.82 | KMT2A (0.45) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL17064934 | 0.82 | KMT2A (0.45) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL16050150 | 0.82 | MAPK1 (0.56) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL12832342 | 0.81 | POLB (0.42) | CYP1A2CYP2C19NPC1RAB9AGAA | |
| SCHEMBL18029568 | 0.81 | MAPK1 (0.54) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL597455 | 0.80 | LMNA (0.60) | MAPK1CYP1A2CYP2C19HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242531-A1 | Monoacylglycerol Lipase Modulators | JANSSEN PHARMACEUTICA NV (BE) | 2023-08-03 | — | — | US | disclosed |
| WO-2020065614-A1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-04-02 | — | — | WO | disclosed |
| US-9173400-B2 | Anthranilamide arthropodicide treatment | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-11-03 | — | — | US | disclosed |
| US-9113630-B2 | Method of controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-08-25 | — | — | US | disclosed |
| US-20140140973-A1 | METHOD OF CONTROLLING PARTICULAR INSECT PESTS BY APPLYNG ANTHRANILAMIDE COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140141972-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E I DU PONT NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | US | disclosed |
| US-8697734-B2 | Method for controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-04-15 | — | — | US | disclosed |
| US-8637552-B2 | Anthranilamide arthropodicide treatment | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-01-28 | — | — | US | disclosed |
| US-20130031677-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-31 | — | — | US | disclosed |
| US-20130028879-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-31 | — | — | US | disclosed |
| US-20060079561-A1 | Insecticidal anthranilamides | FMC CORPORATION | 2006-04-13 | — | — | US | disclosed |
| US-6995178-B2 | Insecticidal anthranilamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-02-07 | — | — | US | disclosed |
| CN-1713819-A | Anthranilamide arthropodicide treatment | DU PONT (US) | 2005-12-28 | — | — | CN | disclosed |
| US-20050075372-A1 | Method for controlling particular insect pest by applying anthranilamide compounds | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-04-07 | — | — | US | disclosed |
| CN-1541063-A | Method for controlling particular insects by applying anthranilamide compounds | ��Ļ���Ű˾ | 2004-10-27 | — | — | CN | disclosed |
| US-20040209923-A1 | Anthranilamide arthropodicide treatment | FMC CORPORATION | 2004-10-21 | — | — | US | disclosed |
| US-20040142984-A1 | Insecticidal anthranilamides | FMC CORPORATION | 2004-07-22 | — | — | US | disclosed |
| US-6747047-B2 | ARTHROPODICIDES | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-06-08 | — | — | US | disclosed |
| US-20030229050-A1 | Insecticidal anthranilamides | FMC CORPORATION | 2003-12-11 | — | — | US | disclosed |
| CN-1419537-A | Insecticidal anthranilamides | DU PONT (US) | 2003-05-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242531-A1 | Monoacylglycerol Lipase Modulators | MGLL, LPL, PNLIP | MAPK1 4069/4885CYP1A2 767/4885CYP2C19 561/4885 |
| US-20140140973-A1 | METHOD OF CONTROLLING PARTICULAR INSECT PESTS BY APPLYNG ANTHRANILAMIDE COMPOUNDS | ANTXR2, NIT2, TDO2 | MAPK1 2686/4885CYP1A2 153/4885CYP2C19 912/4885 |
| US-20130031677-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | MAPK1 400/4885CYP1A2 639/4885CYP2C19 2221/4885 |
| US-20040142984-A1 | Insecticidal anthranilamides | ANTXR2, NIT2, AKR7A2 | MAPK1 1213/4885CYP1A2 15/4885CYP2C19 885/4885 |
| US-20040209923-A1 | Anthranilamide arthropodicide treatment | ANTXR2, ARF5, NPM1 | MAPK1 151/4885CYP1A2 455/4885CYP2C19 2492/4885 |
| US-20060079561-A1 | Insecticidal anthranilamides | ANTXR2, CYB5R3, NIT2 | MAPK1 1311/4885CYP1A2 8/4885CYP2C19 272/4885 |
| US-20030229050-A1 | Insecticidal anthranilamides | ANTXR2, NIT2, CYB5R3 | MAPK1 1291/4885CYP1A2 10/4885CYP2C19 639/4885 |
| US-20130028879-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | ANTXR2, CYP4X1, PRDX1 | MAPK1 2641/4885CYP1A2 170/4885CYP2C19 377/4885 |
| US-20050075372-A1 | Method for controlling particular insect pest by applying anthranilamide compounds | ANTXR2, HRH4, HDAC10 | MAPK1 1809/4885CYP1A2 324/4885CYP2C19 1030/4885 |
| US-20140141972-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | MAPK1 400/4885CYP1A2 639/4885CYP2C19 2221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.